Skip to main content
FinSpry Logo
FinSpry
ANAB logo
ANAB
(NASDAQ)
AnaptysBio, Inc.
$56.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AnaptysBio (ANAB) Stock Price & Financial Analysis

AnaptysBio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$54.79 - $58.17
52-Week High$73.30
52-Week Low$17.11
Open$55.48
Volume1.03M
Average Volume (3M)458.35K
Market Cap1.63B
Shares Outstanding28.69M
Price to Sales (P/S)7.01
Price to Book (P/B)127.85
EV/EBITDA32.62
Revenue (TTM)232.39M
Net Income (TTM)-26.79M
Free Cash Flow (TTM)4.41M
EPS (TTM)$-0.91
Profit Margin-11.53%
Operating Margin17.56%
Return on Equity (ROE)-210.14%
Debt to Equity21.76
50-Day MA$58.05
200-Day MA$55.55
52-Week Change155.07%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About AnaptysBio

What is the current stock price for ANAB?

As of the latest trading session, ANAB stock trades at $56.60. The 52-week range is $17.11–$73.30, with a day range of $54.79–$58.16.

What is the P/E ratio for ANAB?

The P/E ratio (Price-to-Earnings) for ANAB is shown in the Key Statistics section. This valuation metric helps compare AnaptysBio, Inc. to industry peers.

Does ANAB pay dividends?

AnaptysBio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ANAB?

Based on 5 analysts, the consensus for ANAB is Buy.

What is the market cap of ANAB?

AnaptysBio's market capitalization is $1.62B, classifying it as a small-cap company. AnaptysBio operates in the Healthcare sector within the Biotechnology industry.